AU2003282709A8 - Gene expression profiling of bladder cancer - Google Patents

Gene expression profiling of bladder cancer

Info

Publication number: AU2003282709A8
Authority: AU; Australia
Prior art keywords: gene expression; bladder cancer; expression profiling; profiling; bladder
Prior art date: 2002-10-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003282709A

Other versions

AU2003282709A1 (en

Inventor

Geoffrey Childs

Carlos Cordon-Cardo

Marta Sanchez-Carbayo

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Memorial Sloan Kettering Cancer Center

Original Assignee

Memorial Sloan Kettering Cancer Center

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-04

Filing date

2003-10-03

Publication date

2004-05-04

2003-10-03 Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center

2004-05-04 Publication of AU2003282709A8 publication Critical patent/AU2003282709A8/en

2004-05-04 Publication of AU2003282709A1 publication Critical patent/AU2003282709A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Biophysics (AREA)
Oncology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2003282709A 2002-10-04 2003-10-03 Gene expression profiling of bladder cancer Abandoned AU2003282709A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US41600202P	2002-10-04	2002-10-04
US41600302P	2002-10-04	2002-10-04
US60/416,003		2002-10-04
US60/416,002		2002-10-04
PCT/US2003/031620 WO2004033641A2 (en)	2002-10-04	2003-10-03	Gene expression profiling of bladder cancer

Publications (2)

Publication Number	Publication Date
AU2003282709A8 true AU2003282709A8 (en)	2004-05-04
AU2003282709A1 AU2003282709A1 (en)	2004-05-04

Family

ID=32096131

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003282709A Abandoned AU2003282709A1 (en)	2002-10-04	2003-10-03	Gene expression profiling of bladder cancer

Country Status (2)

Country	Link
AU (1)	AU2003282709A1 (en)
WO (1)	WO2004033641A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006007249B4 (en) *	2006-02-15	2008-07-31	Universitätsklinikum Schleswig-Holstein	Method for the determination of bladder carcinomas of differentiation grade G2
WO2011016031A2 (en)	2009-08-03	2011-02-10	Yeda Research And Development Co. Ltd.	Urinary biomarkers for cancer diagnosis
WO2022256743A1 (en) *	2021-06-04	2022-12-08	Cedars-Sinai Medical Center	Use of cancer cell expression of cadherin 12 and cadherin 18 to treat bladder cancers
WO2023215278A1 (en) *	2022-05-03	2023-11-09	The Broad Institute, Inc.	Modified immune cells and methods for use thereof
CN119162315A (en) *	2024-08-21	2024-12-20	兰州大学	A bladder cancer molecular marker AP2S1 and its application

2003
- 2003-10-03 WO PCT/US2003/031620 patent/WO2004033641A2/en not_active Ceased
- 2003-10-03 AU AU2003282709A patent/AU2003282709A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004033641A3 (en)	2006-08-24
WO2004033641A2 (en)	2004-04-22
AU2003282709A1 (en)	2004-05-04

Publication	Publication Date	Title
AU2003253860A8 (en)	2004-01-23	Expression profile of lung cancer
EP1482970A4 (en)	2006-01-18	Cancer therapy
AU2003294205A8 (en)	2004-04-23	Prostate cancer biomarkers
AU2003224598A1 (en)	2003-09-02	Differentially-regulated prostate cancer genes
AU2003279101A8 (en)	2004-04-23	Methylation profile of cancer
GB0327384D0 (en)	2003-12-31	Gene therapy
AU2003282709A8 (en)	2004-05-04	Gene expression profiling of bladder cancer
AU2003212826A1 (en)	2003-09-02	Cancer genes
GB0210741D0 (en)	2002-06-19	Methods of therapy
GB0226595D0 (en)	2002-12-24	Cancer therapy determination
AU2003231803A8 (en)	2003-12-02	Treatment of cancer with mefloquire
AU2003256931A8 (en)	2004-02-16	Uses of circadian gene mper2
GB0329416D0 (en)	2004-01-21	Treatment of cancer
AU2003292227A1 (en)	2004-07-09	Combined antisense oligonucleotide cancer therapy
AU2003294705A8 (en)	2004-06-07	Ntsm gene
GB2383538B (en)	2003-11-19	Cancer treatment
EP1669452A4 (en)	2007-06-27	Promoter of synoviolin gene
AU2003262815A8 (en)	2004-03-11	New tumor suppressor genes and their uses
EP1518929A4 (en)	2005-11-23	Novel genes
GB0209138D0 (en)	2002-05-29	Gene expression
AU2002950424A0 (en)	2002-09-12	Breast cancer gene
TW562061U (en)	2003-11-11	Structure of shaping forms
AU2003217925A1 (en)	2003-09-16	Treatment of metastatic institute for cancer
GB0327667D0 (en)	2003-12-31	Treatment of cancer
AU2003260820A8 (en)	2004-02-25	Nephritis treatment by gene therapy

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase